Similar articles

• Pathobiochemistry and clinical use of procalcitonin.

  Meisner M. Meisner M. Clin Chim Acta. 2002 Sep;323(1-2):17-29. doi: 10.1016/s0009-8981(02)00101-8. Clin Chim Acta. 2002. PMID: 12135804 Review.
• [Participation of procalcitonin in inflammatory response after cardiovascular surgery].

  Paśnik J. Paśnik J. Postepy Hig Med Dosw (Online). 2004;58:522-9. Postepy Hig Med Dosw (Online). 2004. PMID: 15765014 Review. Polish.
• Procalcitonin as an acute phase marker.

  Whicher J, Bienvenu J, Monneret G. Whicher J, et al. Ann Clin Biochem. 2001 Sep;38(Pt 5):483-93. doi: 10.1177/000456320103800505. Ann Clin Biochem. 2001. PMID: 11587126 Review.
• Use of quantitative and semiquantitative procalcitonin measurements to identify children with sepsis and meningitis.

  Prat C, Domínguez J, Rodrigo C, Giménez M, Azuara M, Blanco S, Ausina V. Prat C, et al. Eur J Clin Microbiol Infect Dis. 2004 Feb;23(2):136-8. doi: 10.1007/s10096-003-1066-4. Epub 2003 Dec 19. Eur J Clin Microbiol Infect Dis. 2004. PMID: 14689316 No abstract available.
• Calcitonin gene related peptide and N-procalcitonin modulate CD11b upregulation in lipopolysaccharide activated monocytes and neutrophils.

  Monneret G, Arpin M, Venet F, Maghni K, Debard AL, Pachot A, Lepape A, Bienvenu J. Monneret G, et al. Intensive Care Med. 2003 Jun;29(6):923-928. doi: 10.1007/s00134-003-1759-2. Epub 2003 Apr 24. Intensive Care Med. 2003. PMID: 12712241